tiprankstipranks
Trending News
More News >
Biolife Sciences Inc. (BLFE)
:BLFE
US Market
Advertisement

Biolife Sciences (BLFE) Income Statement

Compare
56 Followers

Biolife Sciences Income Statement

Last quarter (Q1 2022), Biolife Sciences's total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Biolife Sciences's net income was $―. See Biolife Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 20Dec 19Dec 18Dec 17Dec 16
Total Revenue
$ 411.69K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -985.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 259.16K$ 0.00$ 42.28K$ 329.13K$ 12.50K
Depreciation and Amortization
$ 206.30K$ 171.86K$ 0.00$ 0.00$ 0.00
EBITDA
$ -1.22M$ 171.86K$ -42.28K$ -329.13K$ -12.50K
Operating Income
$ -1.24M$ 0.00$ -42.28K$ -329.13K$ -12.50K
Other Income/Expenses
$ -24.04K$ -1.13K$ -10.44K$ -11.26K$ -6.67K
Pretax Income
$ -1.27M$ -1.13K$ -52.72K$ -340.39K$ -19.18K
Net Income
$ -1.27M$ -1.13K$ -52.72K$ -340.39K$ -19.18K
Per Share Metrics
Basic EPS
$ -0.02$ 0.00$ 0.00$ -0.08$ -0.05
Diluted EPS
$ -0.02$ 0.00$ 0.00$ -0.08$ -0.05
Weighted Average Shares Outstanding
51.78M 19.45M 19.45M 4.45M 421.26K
Weighted Average Shares Outstanding (Diluted)
51.78M 19.45M 19.45M 4.45M 421.26K
Currency in USD

Biolife Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis